HBI
56
3
LMT
44
5
CTAS
42
2
NRG
39
4
FTI
63
2
PLD
40
2
TROW
48
6
AMP
50
3
KO
46
4
RHI
50
2
INTC
40
3
AMT
33
3
AXP
67
4
RF
44
3
GLW
48
4
GM
61
4
CAH
47
2
PWR
66
3
AMG
52
3
WAT
59
4
HBI
56
3
LMT
44
5
CTAS
42
2
NRG
39
4
FTI
63
2
PLD
40
2
TROW
48
6
AMP
50
3
KO
46
4
RHI
50
2
INTC
40
3
AMT
33
3
AXP
67
4
RF
44
3
GLW
48
4
GM
61
4
CAH
47
2
PWR
66
3
AMG
52
3
WAT
59
4
Financhill
Back

ProShares Short 20+ Yr Treasury Vs. Aligos Therapeutics Industry Stock Comparison

Buy
62

TBF
ProShares Short 20+ Yr Treasury

Last Price:
$24.59
Seasonality Move:
1.21%
Buy
62

ALGS
Aligos Therapeutics

Last Price:
$41.25
Seasonality Move:
7.18%
Buy
62
ProShares Short 20+ Yr Treasury (TBF) is a Buy

Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?

  • The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.46. The Score for TBF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • TBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $39.34. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TBF Stock Price Chart

What is ProShares Short 20+ Yr Treasury's stock price today?

  • The ProShares Short 20+ Yr Treasury share price today is $24.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing selling pressure, which indicates risk of future bearish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $39.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

TBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 64.78 Buy
Chaikin Money Flow: -20952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.24 - 24.24) Buy
Bollinger Bands (100): (22.17 - 23.77) Buy

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.44 Buy
Relative Strength Index (14 RSI): 77.53 Buy
Chaikin Money Flow: -217768 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (21.98 - 35.56) Buy
Bollinger Bands (100): (6.92 - 24.5) Buy

TBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.24 Buy
20-day SMA: 23.66 Buy
50-day SMA: 23.65 Buy
200-day SMA: 23.42 Buy
8-day EMA: 24.23 Buy
20-day EMA: 23.91 Buy
50-day EMA: 23.59 Buy
200-day EMA: 23.32 Buy

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.44 Buy
20-day SMA: 31.12 Buy
50-day SMA: 19.88 Buy
200-day SMA: 16.4 Buy
8-day EMA: 36.62 Buy
20-day EMA: 31.53 Buy
50-day EMA: 23.66 Buy
200-day EMA: 17.85 Buy

ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

ProShares Short 20+ Yr Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):